Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

434
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
434
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

358
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
358
Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
285
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study.

RMD open·2026
Same author

Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study.

Rheumatology (Oxford, England)·2026
Same author

Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5.

Lupus science & medicine·2026
Same author

Kidney biopsy during pregnancy: indications, complications, results and therapeutic impact.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

[Proposals from the French National Society of Internal Medicine on care pathways for patients with medical emergencies].

La Revue de medecine interne·2026
Same author

Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort.

RMD open·2026

Related Experiment Video

Updated: Jul 1, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

Issues with pregnancy in systemic lupus.

Véronique Le Guern1, Gaelle Guettrot-Imbert2, Anastasia Dupré1

  • 1Service de médecine interne, Centre de références maladies auto-immunes et systémiques rares d'Île-de-France, Cochin, AP-HP, Paris, France.

Joint Bone Spine
|March 6, 2024
PubMed
Summary
This summary is machine-generated.

Pregnancy in women with systemic lupus erythematosus (SLE) is generally safe with proper planning and disease control. Key risk factors for complications and flares are identified to improve maternal and fetal outcomes.

Keywords:
Adverse obstetrical outcomeContraceptionHydroxychloroquinePreconception counsellingPregnancySystemic lupus erythematosus

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.6K

Related Experiment Videos

Last Updated: Jul 1, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.6K

Area of Science:

  • Rheumatology
  • Obstetrics
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) disproportionately affects young women of childbearing age.
  • While pregnancy is often safe in SLE patients with controlled disease, risks of maternal complications are elevated compared to the general population.
  • Effective contraception and preconception counseling are crucial for managing pregnancies in women with SLE, especially those on teratogenic treatments or with active disease.

Purpose of the Study:

  • To summarize risk factors for adverse obstetric outcomes in pregnant women with SLE.
  • To enhance medical and obstetric management strategies for this patient group.
  • To provide insights into predicting and mitigating pregnancy-related risks in SLE.

Main Methods:

  • Review of recent prospective studies identifying risk factors for obstetric complications and SLE flares.
  • Analysis of predictive factors for disease flares, including lupus activity, complement levels, primigravida, and lupus nephritis history.
  • Evaluation of predictors for obstetric events, such as antiphospholipid syndrome, antiphospholipid antibodies, and lupus damage/activity.

Main Results:

  • High lupus activity, low complement, primigravida, and history of lupus nephritis predict disease flares.
  • Antiphospholipid syndrome/antibodies, lupus damage, and activity predict obstetric events.
  • Hydroxychloroquine continuation is recommended; lowest effective doses of corticosteroids and certain immunosuppressants are advised. Low-dose aspirin is used for those with a history of lupus nephritis.

Conclusions:

  • Strategic planning, including effective contraception and preconception counseling, is vital for pregnant women with SLE.
  • Identifying and managing specific risk factors can improve pregnancy outcomes.
  • Continued use of hydroxychloroquine and appropriate management of disease activity and specific conditions like lupus nephritis are key to safe pregnancies in SLE patients.